
Health Net is owned by Centene Corporation (NYSE: CNC), which acquired Health Net, Inc. in March 2016 for approximately $6.8 billion. Founded in 1977 in California, Health Net now serves about three million members across the state through Medi-Cal managed care, Medicare Advantage, Ambetter marketplace plans, and employer group coverage, with a network of more than 118,000 providers. Health Net operates as Centene's flagship California brand, headquartered in Woodland Hills.
Parent Company
Acquired
2016
Status
Publicly Traded
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Health Net | Centene Corporation | Wholly owned |
Health Net traces its origins to 1977, when nonprofit group health plans began operating in California. The organization consolidated through the 1980s, and Health Net became one of the state's largest health maintenance organizations, later restructuring as a for-profit managed care company. A 1997 merger with Foundation Health Corporation created Foundation Health Systems, which adopted the Health Net name in 2000.
Through the 1990s and 2000s, Health Net expanded into Medicare Advantage, managed Medicaid, behavioral health, and government contracts, including a major TRICARE contract serving military families. It also acquired Northeast health plans and operated in Arizona, Oregon, and Washington before concentrating on California.
In July 2015, Centene announced it would acquire Health Net for approximately $6.8 billion. The deal closed March 24, 2016, following antitrust review and required divestitures in California. Post-merger, Health Net became Centene's California arm, absorbing the state's Medi-Cal contracts and adding Ambetter marketplace plans underwritten by Health Net of California.
Between 2023 and 2026, Health Net's Medi-Cal footprint shifted as California re-procured managed care contracts. Its direct-service counties now include Los Angeles, Sacramento, San Joaquin, Stanislaus, Tulare, Amador, Calaveras, Inyo, Mono, and Tuolumne, alongside subcontracted arrangements in other markets. In January 2024, California launched a statewide Medi-Cal Rx carve-out (Medi-Cal Rx), separating pharmacy benefits from managed care plans including Health Net.
Is Centene a subsidiary of another company?
No, Centene Corporation is an independent, publicly traded corporation with no parent company. The company operates independently with its own management structure and board of directors, though it has grown through numerous acquisitions throughout its history, including the transformative $17.3 billion acquisition of WellCare Health Plans in January 2020.
Is Centene publicly traded?
Yes, Centene Corporation is publicly traded on the New York Stock Exchange under the ticker symbol CNC. The company has been publicly traded since its IPO in 2001, when it had three health plans, $327 million in revenue, and 235,000 members. As of 2025, the company is ranked No. 23 on the Fortune 500 list.
When was Centene founded?
Centene traces its origins to 1984 when Elizabeth Brinn founded Managed Health Services as a non profit organization in Milwaukee, Wisconsin. The company was renamed Centene Corporation in 1997 when Michael Neidorff was named President and CEO, and the corporate office was established in St. Louis, Missouri. The company went public in 2001.
Who founded Centene?
Centene was founded by Elizabeth Brinn in 1984 as Managed Health Services, a non profit organization focused on providing healthcare services to Medicaid populations in Milwaukee, Wisconsin. After her death, the organization was converted to a for profit company. Michael Neidorff was named CEO in 1997 and grew Centene from a local health plan to a national healthcare leader over 25 years.
What is Centene's annual revenue?
For fiscal year 2025 (ended December 31, 2025), Centene reported total revenue of $194.8 billion, a 19% increase from $163.1 billion in FY2024. Premium and service revenues were $174.6 billion, up 20% year over year. The company recorded a GAAP net loss of $6.7 billion, primarily due to a $6.7 billion non cash goodwill impairment charge. Adjusted diluted EPS was $2.08, down from $7.17 in FY2024.
What is Centene's market position?
Centene is the largest Medicaid managed care organization in the United States, the longest running carrier in the Health Insurance Marketplace, and a national leader in Medicare Prescription Drug Plans. The company serves 27.6 million members across all 50 states as of December 31, 2025, with revenue from Medicaid (57%), Commercial (21%), Medicare (19%), and Other (3%) segments. Centene is ranked No. 23 on the Fortune 500 and No. 42 on the Fortune Global 500.
Who is Centene's CEO?
Sarah M. London has served as Chief Executive Officer of Centene Corporation since 2022. She is the first woman to lead the company. Under her leadership, Centene has refocused on three core lines of business: Medicaid, Medicare, and the Health Insurance Marketplace. In 2025, London navigated the company through significant challenges including the $6.7 billion goodwill impairment, Marketplace risk adjustment shortfall, and elevated Medicaid medical cost trends.
What is the WellCare acquisition?
In January 2020, Centene completed the acquisition of WellCare Health Plans in a $17.3 billion transaction (enterprise value). WellCare shareholders received 3.38 shares of Centene common stock and $120 in cash for each share of WellCare common stock. The acquisition made Centene a nationwide company serving all 50 states with approximately 24 million members, expanded its Medicare platform, and extended its Medicaid offerings. WellCare became a wholly owned subsidiary of Centene and continues to operate as a brand under the Centene umbrella.
Health Net operates under Centene's corporate social responsibility framework, emphasizing health equity, culturally and linguistically appropriate services, and community investment in California. Health Net Community Solutions funds community health workers, housing support, and social determinants of health programs aligned with California's CalAIM initiative, which restructured Medi-Cal to address homelessness, behavioral health, and whole-person care.
The plan holds NCQA accreditation and is subject to California Department of Health Care Services quality reporting. Like other Medi-Cal plans, Health Net is audited on access standards, grievance handling, and encounter data accuracy.
Health Net's Medi-Cal and Medicare plans hold NCQA accreditation. CalViva Health, Health Net's county-organized health system joint venture, has been cited by California regulators as a model for publicly governed Medi-Cal contracting. Health Net has also received employer and community recognition for its mobile health screening units and farmworker health initiatives in the Central Valley.
Rescission Scandal (2000s): Before the Centene acquisition, Health Net was one of several California insurers caught in the mid-2000s rescission scandal, canceling individual policyholders' coverage after claims were filed. The company paid millions in settlements and regulatory fines, and the practice drove California's eventual regulatory reforms banning most retroactive cancellations.
Centene Medicaid Settlement: Parent company Centene agreed to a multistate settlement exceeding $1 billion beginning in 2021 over allegations that its pharmacy benefit manager practices overcharged state Medicaid programs, a matter that predated but encompassed acquired subsidiaries' oversight.
Medi-Cal Transition Disruptions: California's 2023 to 2025 Medi-Cal managed care procurement reassignments and the January 2024 Medi-Cal Rx pharmacy carve-out caused coverage transitions for hundreds of thousands of Health Net members, drawing member complaints about authorization and continuity-of-care disruptions.
Behavioral Health Compliance: California regulators have periodically cited Medi-Cal plans, including Health Net, over timely-access standards and behavioral health care coordination, an area of ongoing corrective action plans across the industry.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Elevance Health | USA | 2024 | Mass market | United states | All-ages | |
| Centene | USA | 1993 | Market leader | United states | All-ages | |
| Centene | USA | 1985 | Mass market | United states | All-ages | |
| Humana | USA | 1990 | Growth segment | United states | All-ages | |
| Humana | USA | 1985 | Market leader | United states | Seniors-65-plus | |
| Molina Healthcare | USA | 1980 | Mass market | United states | All Genders |
Healthcare PharmaceuticalsOwned by Elevance Health Inc.
Elevance Health's government health plan brand for Medicaid, CHIP, and Medicare in states where Anthem Blue Cross Blue Shield does not operate, rebranded from Amerigroup in January 2024.
Healthcare PharmaceuticalsOwned by Centene Corporation
Centene Corporation's New York State health plan, founded in 1993 by the Catholic bishops of New York and acquired for $3.75 billion in July 2018, serving more than 2.4 million members.
Healthcare PharmaceuticalsOwned by Centene Corporation
Centene Corporation's national Medicare Advantage and prescription drug plan brand, acquired from WellCare Health Plans for $17.3 billion in January 2020.
Healthcare PharmaceuticalsOwned by Humana Inc.
Humana's Medicaid managed care product line operating as Humana Healthy Horizons across 13 states, with Georgia and Texas launches planned and D-SNP growth of 18 percent in 2026.
Healthcare PharmaceuticalsOwned by Humana Inc.
Humana's Medicare product line, the second-largest Medicare Advantage insurer in the United States, which grew membership about 20 percent in the 2026 annual enrollment period.
InsuranceOwned by Molina Healthcare, Inc.
American managed care brand providing Medicaid, Medicare Advantage, and Marketplace health plans to approximately 5.5 million members in 21 states.
Market Positioning: Health Net competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Centene Corporation, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Boots is the UK's leading pharmacy-led health and beauty retailer, founded in 1849, now operating as The Boots Group under Sycamore Partners since August 2025.
Boots is privately owned, unlike Health Net which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Duane Reade is a New York City drugstore chain owned by Walgreen Co. under Sycamore Partners, operating approximately 90 stores across the five boroughs.
Duane Reade is privately owned, unlike Health Net which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Chempro Chemists
Australian online pharmacy operated by Chempro Chemists from Molendinar, Queensland. Offers prescription medications, health products, and wellness items through digital platforms and mail-order delivery.
Pharmacy Direct is privately owned, unlike Health Net which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Walgreens Boots Alliance
Walgreens is the largest U.S. pharmacy retail brand, operating roughly 8,000 stores. It went private in August 2025 under Sycamore Partners as a standalone company.
Walgreens is privately owned, unlike Health Net which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by IBSA Institut Biochimique S.A.
IBSA Institut Biochimique SA's branded levothyroxine softgel capsule (Tirosint) and liquid solution (Tirosint-SOL), FDA approved for hypothyroidism, formulated without dyes, gluten, lactose, alcohol, or sugar, providing an excipient-free alternative to conventional levothyroxine tablets for patients with sensitivities or absorption issues.
Tirosint is privately owned, unlike Health Net which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by GoodRx Holdings, Inc.
American healthcare technology platform providing prescription drug price comparison, discount coupons, and telehealth services to help consumers find affordable healthcare options.
GoodRx operates independently without a large parent corporation.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.